dulanermin
Sponsors
Genentech, Inc.
Conditions
Colorectal CancerMetastatic Colorectal CancerNon-Hodgkin's Lymphoma
Phase 1
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas
TerminatedNCT00400764
Start: 2006-06-30Updated: 2011-11-23
A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer
CompletedNCT00671372
Start: 2006-07-31End: 2012-03-31Updated: 2016-11-02
A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
CompletedNCT00873756
Start: 2009-05-31End: 2014-04-30Updated: 2016-11-02